A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(45 sites)

United States

Central Alabama Research, Birmingham, Alabama

University of Alabama at Birmingham, Birmingham, Alabama

Ironwood Cancer and Research Centers, Chandler, Arizona

University of Arizona, Tucson, Arizona

University of California San Diego, La Jolla, California